封面
市场调查报告书
商品编码
1946582

2026年全球就地检验市场报告

Neonatal Point Of Care Testing Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,新生儿就地检验市场发展迅速,预计将从2025年的13.2亿美元成长到2026年的15.2亿美元,复合年增长率达14.5%。过去几年的成长可归因于多种因素,例如人们对新生儿死亡率的认识不断提高、医院引入快速检测设备、政府对新生儿护理的支持、产科诊所的扩张以及床边检测技术的进步。

预计未来几年,新生儿就地检验市场规模将快速成长,到2030年将达到25.9亿美元,复合年增长率(CAGR)为14.3%。预测期内的成长可归因于人工智慧诊断解决方案的兴起、新生儿资料管理的云端整合、携带式小型照护现场设备的普及、新生儿护理领域公私合营的增加以及新兴经济体新生儿医疗保健基础设施的不断完善。预测期内的关键趋势包括:基于人工智慧的新生儿诊断、基于云端的照护现场平台、携带式检测设备、即时数据分析以及用于新生儿监测的物联网整合。

预计未来几年,对远端患者监护日益增长的需求将推动新生儿就地检验市场的发展。远端患者监护透过连接患者和医疗专业人员的技术提供医疗保健服务。尤其对于偏远和医疗服务不足地区的患者而言,对便利医疗保健的需求不断增长,推动了对远端患者监护的需求。新生儿就地检验透过提供快速的床边诊断结果来支援远端患者监护,使医疗专业人员能够快速检测和处理新生儿的严重,而无需依赖中心检查室。例如,根据美国医疗科技公司Vivalink在2023年8月进行的一项调查,84%的现有远距病患监测(RPM)使用者计画在2024年扩大其使用范围,45%的医疗机构正在将RPM应用于家庭医院计画的急性监护。此外,77%的受访者预测,基于RPM的照护将在未来五年内超越传统的住院照护。因此,对远端患者监护日益增长的需求预计将推动新生儿就地检验市场的发展。

新生儿就地检验市场的主要企业正在建立策略联盟,旨在扩大诊断的可及性并改善新生儿的早期护理。策略联盟是指各组织为了实现通用目标而整合资源和专业知识的伙伴关係。例如,2025年1月,总部位于荷兰的样本和检测技术供应商QIAGEN与英国基因组学机构Genomics England建立了合作关係。此次合作将支持「世代研究」(Generation Study)的推出,计划旨在对英国10万名新生儿的基因组进行定序,并识别200多种可治疗的遗传疾病。 QIAGEN将为照护现场定序中评估的基因提供具有临床意义的遗传变异数据,从而加快分析和报告结果的速度。研究计画于2024年10月正式启动,预计将改善英国每年约3,000名新生儿所患疾病的早期检测和治疗。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球新生儿就地检验市场:吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧(AI)和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 基于人工智慧的新生儿诊断
    • 基于云端的即时护理平台
    • 携带式检测装置
    • 即时数据分析
    • 物联网在新生儿监护的应用

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 妇产科诊所
  • 专科诊所
  • 研究所

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球新生儿就地检验市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 全球新生儿就地检验市场规模、对比及成长率分析
  • 全球新生儿就地检验市场表现:规模与成长,2020-2025年
  • 全球新生儿就地检验市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场规模(TAM)

第九章 市场细分

  • 副产品
  • 设备、检测
  • 按测试类型
  • 新生儿胆红素检测、血糖检测、传染病筛检、电解质检测及其他检测项目
  • 最终用户
  • 医院、妇产科和专科诊所及其他最终用户
  • 按类型细分:设备
  • 血液气体分析仪、胆红素测量仪、血糖测量仪
  • 按类型细分:侦测
  • 胆红素测定、葡萄糖测定、感染疾病测定、电解质测定、血气测定

第十章 区域与国家分析

  • 全球新生儿就地检验市场:区域分析、预测(2020-2025年、2025-2030年预测、2035年预测)
  • 全球新生儿就地检验市场:国家、市场表现及预测,2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 新生儿就地检验市场:竞争格局及市场占有率(2024年)
  • 新生儿就地检验市场:公司估值矩阵
  • 新生儿就地检验市场:公司概况
    • Abbott Laboratories
    • Siemens Healthineers AG
    • GE Healthcare Technologies Inc.
    • Koninklijke Philips NV
    • Roche Diagnostics International AG

第37章:其他领先和创新企业

  • Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix Srl, GINEVRI Srl

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年新生儿就地检验市场:提供新机会的国家
  • 2030年新生儿就地检验市场:充满新机会的细分市场
  • 2030年新生儿就地检验市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MNPCT01_G26Q1

Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.

The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.

Tariffs are impacting the neonatal point of care testing market by increasing the cost of imported instruments, reagents, and kits. This has slowed adoption in hospitals and maternity clinics in regions such as Asia-Pacific and Europe. Instruments like blood gas analyzers and bilirubinometers are most impacted. Positive impacts include encouragement of local manufacturing and domestic reagent production, which improves supply chain resilience and lowers long-term operational costs.

The neonatal point of care testing market research report is one of a series of new reports from The Business Research Company that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing neonatal mortality awareness, adoption of rapid testing devices in hospitals, government support for neonatal care, expansion of maternity clinics, technological improvements in bedside testing.

The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.59 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise of AI-based diagnostic solutions, cloud integration for neonatal data management, portable and compact point-of-care devices, increasing private-public partnerships in newborn health, growth in emerging economies' neonatal healthcare infrastructure. Major trends in the forecast period include AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, integration of IoT for newborn monitoring.

The rising demand for remote patient monitoring is anticipated to drive the growth of the neonatal point-of-care testing market in the coming years. Remote patient monitoring involves delivering healthcare services through technology that connects patients and healthcare professionals remotely. The increasing demand for remote patient monitoring is driven by the growing need for accessible and convenient healthcare, particularly for patients in remote or underserved regions. Neonatal point-of-care testing supports remote patient monitoring by offering rapid bedside diagnostic results, enabling healthcare providers to promptly detect and manage critical conditions in newborns without dependence on centralized laboratories. For example, in August 2023, according to Vivalink, a US-based healthcare technology company, a recent survey found that 84% of existing remote patient monitoring (RPM) users plan to expand their use in 2024, 45% of healthcare providers are applying RPM for acute monitoring in hospital-at-home programs, and 77% believe RPM-based care will surpass traditional inpatient hospital care within the next five years. Consequently, the growing demand for remote patient monitoring is expected to fuel the growth of the neonatal point-of-care testing market.

Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.

In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company's growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.

Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl

North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Point Of Care Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal point of care testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Instruments; Assay
  • 2) By Test Type: Neonatal Bilirubin Testing; Blood Glucose Testing; Infectious Disease Screening; Electrolyte Testing; Other Test Types
  • 3) By End-Users: Hospitals; Maternity And Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Instruments: Blood Gas Analyzers; Bilirubinometers; Glucose Meters
  • 2) By Assay: Bilirubin Assays; Glucose Assays; Infectious Disease Assays; Electrolyte Assays; Blood Gas Assays
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; GE Healthcare Technologies Inc.; Koninklijke Philips N.V.; Roche Diagnostics International AG; Danaher Corporation; Drager AG & Co. KGaA; Masimo Corporation; Radiometer Medical ApS; Nova Biomedical Corporation; bioMerieux SA; Sysmex Corporation; Nihon Kohden Corporation; Natus Medical Incorporated; Contec Medical Systems Co. Ltd.; Edan Instruments Inc.; Trivitron Healthcare; Bistos Co. Ltd.; Bilimetrix S.r.l.; GINEVRI Srl
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neonatal Point Of Care Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neonatal Point Of Care Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neonatal Point Of Care Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neonatal Point Of Care Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Ai-Enabled Neonatal Diagnostics
    • 4.2.2 Cloud-Based Point-Of-Care Platforms
    • 4.2.3 Portable Testing Devices
    • 4.2.4 Real-Time Data Analysis
    • 4.2.5 Integration Of Iot For Newborn Monitoring

5. Neonatal Point Of Care Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Maternity Clinics
  • 5.4 Specialty Clinics
  • 5.5 Research Institutions

6. Neonatal Point Of Care Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neonatal Point Of Care Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neonatal Point Of Care Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neonatal Point Of Care Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neonatal Point Of Care Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neonatal Point Of Care Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neonatal Point Of Care Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neonatal Point Of Care Testing Market Segmentation

  • 9.1. Global Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Assay
  • 9.2. Global Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
  • 9.3. Global Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Maternity And Specialty Clinics, Other End-Users
  • 9.4. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Gas Analyzers, Bilirubinometers, Glucose Meters
  • 9.5. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays

10. Neonatal Point Of Care Testing Market Regional And Country Analysis

  • 10.1. Global Neonatal Point Of Care Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neonatal Point Of Care Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neonatal Point Of Care Testing Market

  • 11.1. Asia-Pacific Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neonatal Point Of Care Testing Market

  • 12.1. China Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neonatal Point Of Care Testing Market

  • 13.1. India Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neonatal Point Of Care Testing Market

  • 14.1. Japan Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neonatal Point Of Care Testing Market

  • 15.1. Australia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neonatal Point Of Care Testing Market

  • 16.1. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neonatal Point Of Care Testing Market

  • 17.1. South Korea Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neonatal Point Of Care Testing Market

  • 18.1. Taiwan Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neonatal Point Of Care Testing Market

  • 19.1. South East Asia Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neonatal Point Of Care Testing Market

  • 20.1. Western Europe Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neonatal Point Of Care Testing Market

  • 21.1. UK Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neonatal Point Of Care Testing Market

  • 22.1. Germany Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neonatal Point Of Care Testing Market

  • 23.1. France Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neonatal Point Of Care Testing Market

  • 24.1. Italy Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neonatal Point Of Care Testing Market

  • 25.1. Spain Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neonatal Point Of Care Testing Market

  • 26.1. Eastern Europe Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neonatal Point Of Care Testing Market

  • 27.1. Russia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neonatal Point Of Care Testing Market

  • 28.1. North America Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neonatal Point Of Care Testing Market

  • 29.1. USA Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neonatal Point Of Care Testing Market

  • 30.1. Canada Neonatal Point Of Care Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neonatal Point Of Care Testing Market

  • 31.1. South America Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neonatal Point Of Care Testing Market

  • 32.1. Brazil Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neonatal Point Of Care Testing Market

  • 33.1. Middle East Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neonatal Point Of Care Testing Market

  • 34.1. Africa Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neonatal Point Of Care Testing Market Regulatory and Investment Landscape

36. Neonatal Point Of Care Testing Market Competitive Landscape And Company Profiles

  • 36.1. Neonatal Point Of Care Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neonatal Point Of Care Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neonatal Point Of Care Testing Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

37. Neonatal Point Of Care Testing Market Other Major And Innovative Companies

  • Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl

38. Global Neonatal Point Of Care Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neonatal Point Of Care Testing Market

40. Neonatal Point Of Care Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Neonatal Point Of Care Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neonatal Point Of Care Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neonatal Point Of Care Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer